CoChat

Sex- and suicide-specific alterations in the kynurenine pathway in the anterior cingulate cortex in major depression

Open access
Brown, Samara J., Christofides, Katerina, Weissleder, Christin, Huang, Xu-Feng, Shannon Weickert, Cynthia, Lim, Chai K., Newell, Kelly A. · 2024 · Neuropsychopharmacology

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

Major depressive disorder (MDD) is a serious psychiatric disorder that in extreme cases can lead to suicide. Evidence suggests that alterations in the kynurenine pathway (KP) contribute to the pathology of MDD. Activation of the KP leads to the formation of neuroactive metabolites, including kynurenic acid (KYNA) and quinolinic acid (QUIN). To test for changes in the KP, postmortem anterior cingulate cortex (ACC) was obtained from the National Institute of Health NeuroBioBank. Gene expression of KP enzymes and relevant neuroinflammatory markers were investigated via RT-qPCR (Fluidigm) and KP metabolites were measured using liquid chromatography-mass spectrometry in tissue from individuals with MDD (n = 44) and matched nonpsychiatric controls (n = 36). We report increased IL6 and IL1B mRNA in MDD. Subgroup analysis found that female MDD subjects had significantly decreased KYNA and a trend decrease in the KYNA/QUIN ratio compared to female controls. In addition, MDD subjects that died by suicide had significantly decreased KYNA in comparison to controls and MDD subjects that did not die by suicide, while subjects that did not die by suicide had increased KYAT2 mRNA, which we hypothesise may protect against a decrease in KYNA. Overall, we found sex- and suicide-specific alterations in the KP in the ACC in MDD. This is the first molecular evidence in the brain of subgroup specific changes in the KP in MDD, which not only suggests that treatments aimed at upregulation of the KYNA arm in the brain may be favourable for female MDD sufferers but also might assist managing suicidal behaviour.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41386-023-01736-8

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Sex-specific alterations in the kynurenine pathway are present in major depressive disorder. A Kynurenic acid (KYNA) was significantly decreased in females with major depressive disorder (MDD) compared to controls (p = 0.036). KYNA was significantly higher in female controls compared to male controls (p = 0.012). B The KYNA/QUIN ratio was significantly higher in female controls compared to male controls (p = 0.017). There was a trend decrease in the KYNA/QUIN ratio in females with MDD compared to female controls (p = 0.056). C KMO mRNA was significantly higher in male controls compared to female controls (p = 0.004). In females, MDD subjects had a trend increase in KMO mRNA compared to female controls (p = 0.067). D There was a main diagnostic effect for KYAT2 mRNA. KYAT2 mRNA was significantly increased in MDD compared to controls (p = 0.025). E IL1B and (F) IL6 mRNAs were significantly increased in MDD compared to controls (p = 0.017, p = 0.039, respectively). Controls are represented by circles and MDD subjects are represented by squares. Outlined shapes represent male subjects. Bars indicate mean ± SEM. *p < 0.05, **p < 0.01.
Fig. 1 Sex-specific alterations in the kynurenine pathway are present in major depressive disorder. A Kynurenic acid (KYNA) was significantly decreased in females with major depressive disorder (MDD) compared to controls (p = 0.036). KYNA was significantly higher in female controls compared to male controls (p = 0.012). B The KYNA/QUIN ratio was significantly higher in female controls compared to male controls (p = 0.017). There was a trend decrease in the KYNA/QUIN ratio in females with MDD compared to female controls (p = 0.056). C KMO mRNA was significantly higher in male controls compared to female controls (p = 0.004). In females, MDD subjects had a trend increase in KMO mRNA compared to female controls (p = 0.067). D There was a main diagnostic effect for KYAT2 mRNA. KYAT2 mRNA was significantly increased in MDD compared to controls (p = 0.025). E IL1B and (F) IL6 mRNAs were significantly increased in MDD compared to controls (p = 0.017, p = 0.039, respectively). Controls are represented by circles and MDD subjects are represented by squares. Outlined shapes represent male subjects. Bars indicate mean ± SEM. *p < 0.05, **p < 0.01.CC BY · PubMed Central
Fig. 2 Suicide-specific alterations in the kynurenine pathway. A Kynurenic acid (KYNA) was significantly decreased in major depressive disorder subjects that died by suicide (MDD-S) compared to controls (p = 0.011) and decreased compared to MDD subjects that did not die by suicide (MDD-NS) (p = 0.045). B KYAT2 mRNA was significantly increased in MDD-NS compared to controls (p = 0.004). Female subjects are represented by darker colour. Bars indicate mean ± SEM. *p < 0.05, **p < 0.01.
Fig. 2 Suicide-specific alterations in the kynurenine pathway. A Kynurenic acid (KYNA) was significantly decreased in major depressive disorder subjects that died by suicide (MDD-S) compared to controls (p = 0.011) and decreased compared to MDD subjects that did not die by suicide (MDD-NS) (p = 0.045). B KYAT2 mRNA was significantly increased in MDD-NS compared to controls (p = 0.004). Female subjects are represented by darker colour. Bars indicate mean ± SEM. *p < 0.05, **p < 0.01.CC BY · PubMed Central
Fig. 3 Quinolinic acid is positively correlated with age in major depressive disorder. A There was no significant correlation between quinolinic acid (QUIN) and age in controls (p = 0.664). B In major depressive disorder (MDD) there was a strong positive correlation between QUIN and age (rs = 0.575 p < 0.001). C There was no correlation between age and kynurenic acid (KYNA) in controls or (D) in MDD. Males are represented by the outlined shapes.
Fig. 3 Quinolinic acid is positively correlated with age in major depressive disorder. A There was no significant correlation between quinolinic acid (QUIN) and age in controls (p = 0.664). B In major depressive disorder (MDD) there was a strong positive correlation between QUIN and age (rs = 0.575 p < 0.001). C There was no correlation between age and kynurenic acid (KYNA) in controls or (D) in MDD. Males are represented by the outlined shapes.CC BY · PubMed Central
Fig. 4 Overview of the kynurenine pathway in the brain and key findings in MDD. In the brain, tryptophan can be metabolised in glial cells via the kynurenine pathway. Dependent on the cell type different neuroactive metabolites will be produced. Predominantly in microglia, kynurenine is metabolised into quinolinic acid whereas kynurenic acid is primarily produced in astrocytes. In the anterior cingulate cortex, IL6, IL1B and KYAT2 mRNAs were increased in major depressive disorder (MDD) overall. KYAT2 mRNA was increased in MDD subjects that did not die by suicide in comparison to controls. Kynurenic acid was decreased in females with MDD in comparison to female controls and was decreased in MDD subjects that died by suicide in comparison to MDD-non-suicide and controls. Abbreviations: 3-HAO 3-hydroxyanthranilate 3,4-dioxygenase, ACMSD α-amino-β-carboxymuconate-ε-semialdehyde, IDO1 indoleamine 2, 3-dioxygenase, IL interleukin, KAT kynurenine aminotransferase, KMO kynurenine 3-monoxygenase, KYNU kynurinase, MDD major depressive disorder, NAD+ nicotinamide adenine dinucleotide, TDO tryptophan 2,3-dioxygenase, QPRT quinolinic acid phosphoribosyltransferase.
Fig. 4 Overview of the kynurenine pathway in the brain and key findings in MDD. In the brain, tryptophan can be metabolised in glial cells via the kynurenine pathway. Dependent on the cell type different neuroactive metabolites will be produced. Predominantly in microglia, kynurenine is metabolised into quinolinic acid whereas kynurenic acid is primarily produced in astrocytes. In the anterior cingulate cortex, IL6, IL1B and KYAT2 mRNAs were increased in major depressive disorder (MDD) overall. KYAT2 mRNA was increased in MDD subjects that did not die by suicide in comparison to controls. Kynurenic acid was decreased in females with MDD in comparison to female controls and was decreased in MDD subjects that died by suicide in comparison to MDD-non-suicide and controls. Abbreviations: 3-HAO 3-hydroxyanthranilate 3,4-dioxygenase, ACMSD α-amino-β-carboxymuconate-ε-semialdehyde, IDO1 indoleamine 2, 3-dioxygenase, IL interleukin, KAT kynurenine aminotransferase, KMO kynurenine 3-monoxygenase, KYNU kynurinase, MDD major depressive disorder, NAD+ nicotinamide adenine dinucleotide, TDO tryptophan 2,3-dioxygenase, QPRT quinolinic acid phosphoribosyltransferase.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 44

Metadata

Authors
Brown, S. J., Christofides, K., Weissleder, C., Huang, X.-F., Shannon Weickert, C., Lim, C. K., & Newell, K. A.
Affiliations
  • University of Wollongong (AU)
  • Western Sydney University (AU)
  • Institut des Maladies Génétiques Imagine (FR)
  • Neuroscience Research Australia (AU)
Corresponding author
  • Brown, Samara J.
  • Newell, Kelly A.
Venue
Neuropsychopharmacology
Published
2023-09-21
Volume
49
Issue
3
Pages
584-592
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W4386929114
Cited by
44
References
58
Citations by year
2026: 17 · 2025: 9 · 2024: 14 · 2023: 4
FWCI
4.03
Type
journal article
Language
en
Open access
Licence
Locations
  • Neuropsychopharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Online (University of Wollongong) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • Australian Government
  • Office of Health and Medical Research
  • NSW Ministry of Health (1117079)
  • National Institutes of Health
  • Medical Research Council
  • National Health and Medical Research Council (1176503, 1117079)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
major depressive disorder, kynurenine pathway, anterior cingulate cortex, suicide, kynurenic acid, quinolinic acid, interleukin-6, IL1B, sex differences, neuroinflammation, postmortem brain
MeSH terms
Depression, Major Depressive Disorder, Female, Gyrus Cinguli, Humans, Kynurenic Acid, Kynurenine, RNA, Messenger, Suicide, Quinolinic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sex- and suicide-specific alterations in the kynurenine pathway in the anterior cingulate cortex in major depression. https://app.cochat.ai/papers/10.1038/s41386-023-01736-8
The paper
Brown, S. J., Christofides, K., Weissleder, C., Huang, X.-F., Shannon Weickert, C., Lim, C. K., & Newell, K. A. (2024). Sex- and suicide-specific alterations in the kynurenine pathway in the anterior cingulate cortex in major depression. Neuropsychopharmacology. https://doi.org/10.1038/s41386-023-01736-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.